Literature DB >> 12539083

Fluoroquinolone resistance in Streptococcus pyogenes.

Sandra S Richter1, Daniel J Diekema, Kris P Heilmann, Laurel S Almer, Virginia D Shortridge, Rod Zeitler, Robert K Flamm, Gary V Doern.   

Abstract

Streptococcus pyogenes isolated from blood and urine samples obtained from a 78-year-old woman was tested for susceptibility, and fluoroquinolone resistance (minimum inhibitory concentration of levofloxacin, 16 microg/mL) was found. DNA amplification and sequencing revealed a serine81-->tyrosine substitution in gyrA and 2 substitutions in parC: serine79-->phenylalanine and alanine121-->valine. This is the second report of a clinical isolate of S. pyogenes with high-level fluoroquinolone resistance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12539083     DOI: 10.1086/345904

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Streptococcus pyogenes pharyngeal isolates with reduced susceptibility to ciprofloxacin in Spain: mechanisms of resistance and clonal diversity.

Authors:  Sebastián Albertí; Guadalupe Cortés; Cesar García-Rey; Carmen Rubio; Fernando Baquero; José Angel García-Rodríguez; Emilio Bouza; Lorenzo Aguilar
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

2.  Clonal spread of pediatric isolates of ciprofloxacin-resistant, emm type 6 Streptococcus pyogenes.

Authors:  Rodrigo Alonso; Estibaliz Mateo; Marc Galimand; Javier Garaizar; P Courvalin; Ramón Cisterna
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

3.  Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.

Authors:  Renato Pires; Carmen Ardanuy; Dora Rolo; Ana Morais; António Brito-Avô; José Gonçalo-Marques; Josefina Liñares; Ilda Santos-Sanches
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

Review 4.  Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.

Authors:  A Dalhoff
Journal:  Infection       Date:  2012-03-30       Impact factor: 3.553

5.  Prevalence and characterization of invasive isolates of Streptococcus pyogenes with reduced susceptibility to fluoroquinolones.

Authors:  Jeff Powis; Allison McGeer; Carla Duncan; Ryan Goren; Joyce C S de Azavedo; Darrin J Bast; Sylvia Pong-Porter; Tony Mazzulli; Karen Green; Barbara Willey; Donald E Low
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

6.  Fluoroquinolone resistance in invasive Streptococcus pyogenes isolates due to spontaneous mutation and horizontal gene transfer.

Authors:  M W R Pletz; L McGee; C A Van Beneden; S Petit; M Bardsley; M Barlow; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  2006-03       Impact factor: 5.191

7.  Prevalence and clonal characterization of Streptococcus pyogenes clinical isolates with reduced fluoroquinolone susceptibility in Spain.

Authors:  Milagrosa Montes; Esther Tamayo; Beatriz Orden; Julián Larruskain; Emilio Perez-Trallero
Journal:  Antimicrob Agents Chemother       Date:  2009-10-05       Impact factor: 5.191

Review 8.  Disease manifestations and pathogenic mechanisms of Group A Streptococcus.

Authors:  Mark J Walker; Timothy C Barnett; Jason D McArthur; Jason N Cole; Christine M Gillen; Anna Henningham; K S Sriprakash; Martina L Sanderson-Smith; Victor Nizet
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

9.  An intrinsic pattern of reduced susceptibility to fluoroquinolones in pediatric isolates of Streptococcus pyogenes.

Authors:  S Steve Yan; Paul C Schreckenberger; Xiaotian Zheng; Nancy A Nelson; Susan M Harrington; Joyce Tjhio; Daniel P Fedorko
Journal:  Diagn Microbiol Infect Dis       Date:  2008-06-12       Impact factor: 2.803

10.  Global fluoroquinolone resistance epidemiology and implictions for clinical use.

Authors:  Axel Dalhoff
Journal:  Interdiscip Perspect Infect Dis       Date:  2012-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.